Treatment of peripheral sensorineural hearing loss: gene therapy
Authors:
- 29 September 2004
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (S1) , S51-S56
Abstract
Noise, chemicals and genetic defects are all common causes of irreversible hearing loss, which at present have no cure. Gene therapy may soon be utilized in both the protection and the treatment of these exogenous and endogenous sources of hearing loss. Gene therapy technology is rapidly developing and the inner ear is a particularly feasible model for gene therapy. This review outlines our current understanding of the mechanisms behind deafness and prospects for treatment, discusses the inner ear model in detail and reviews the efforts that have been made in inner ear gene therapy. Finally, the proposed next steps will be discussed. The viral mediated delivery of neurotrophins and antoxidants offers imminent promise in preventing and treating exogenous hearing loss and improving cochlear implant therapy.Keywords
This publication has 39 references indexed in Scilit:
- Intrathecal injection of HVJ‐E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in ratsThe FASEB Journal, 2003
- Cochlear Gene TherapyEar & Hearing, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNFMolecular Therapy, 2003
- Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbilsGene Therapy, 2003
- Rapid renewal of auditory hair bundlesNature, 2002
- Overexpression of Copper/Zinc- Superoxide Dismutase Protects from Kanamycin-Induced Hearing LossAudiology and Neurotology, 2001
- A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear functionGene Therapy, 2001
- Transgene Expression in the Guinea Pig Cochlea Mediated by a Lentivirus-Derived Gene Transfer VectorHuman Gene Therapy, 1999
- Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virusGene Therapy, 1998